Maternal Serum Stathmin-1 Levels in Preeclampsia

The goal of this observational study is to investigate maternal serum Stathmin-1 levels in pregnancies affected by preeclampsia compared to healthy gestations. The main questions it aims to answer are: 1. What are the maternal serum Stathmin-1 levels in pregnancies with preeclampsia? 2. How do Stathmin-1 levels differ between preeclampsia with severe features and uncomplicated pregnancies? Researchers will compare Stathmin-1 levels in pregnancies with preeclampsia and preeclampsia with severe features to those in a control group of healthy pregnancies to assess differences in biomarker levels. Participants will undergo blood sample collection at 32-34 weeks of gestation. Have their blood samples processed for Stathmin-1 level measurement using ELISA.